Doctors and patients say the pharmaceutical company Mylan has increased the prices for an EpiPen — the portable device that can stop a potentially life-threatening allergic reaction — from around $100 in 2008 to $500 or more today, NBC News reports.
Following a recall by Mylan's chief competitor last year, the company now enjoys a near monopoly.
EpiPens have a stated expiration date of one year, meaning there is an additional co-pay to refill them annually.
In a statement, Mylan said that the prices have "changed over time to better reflect important product features and the value the product provides."
U.S. & World
Vermont Sen. Bernie Sanders said "there's no reason an EpiPen, which costs Mylan just a few dollars to make, should cost families more than $600. The only explanation for Mylan raising the price by six times since 2009 is that the company values profits more than the lives of millions of Americans."